2: The Science of Sight: Katie Solley and the Quest to Reverse Blindness

While 95% of corneal illnesses are either preventable or treatable, there are millions of people waiting for a corneal transplant. After identifying a gap in the corneal donation process, Katie Solley, cofounder and CEO of Eyedea Medical, has been working with her team to make corneal surgery more accessible worldwide.

In this episode, Katie shares how customer discovery helped her team refine their device and scale without venture-backed funding. Access the episode transcript here.

You'll hear:

• How Katie worked with eye bank technicians to develop a corneal surgical device

• Strategies for startups working to identify and unlock their customer base

• How Eyedea Medical scaled commercialization relying solely on non-dilutive funding

• Lessons learned from stress tests and advice for early-stage innovators 

  
  

Resources:

• • Follow ⁠Eyedea Medical⁠ on LinkedIn
  • Katie serves as an entrepreneur-in-residence for the VentureWell Aspire Medtech program—learn more about our accelerator and Katie’s role here

  
  

Follow VentureWell on LinkedIn, Instagram (@idea2impact), Bluesky (‪@venturewell.bsky.social‬), and Facebook for more stories and insights from entrepreneurs using innovation to change the future of sustainability, healthcare, and tech.